Khiron OTC Stock Today

KHRNF -  USA Stock  

USD 0.22  0.01  4.35%

Khiron Life is trading at 0.22 as of the 24th of October 2021, a -4.35 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.21. Khiron Life has about a 32 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Khiron Life Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of September 2021 and ending today, the 24th of October 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 32
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America, North America, and Europe. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands develops CBD-based cosmeceutical products under the Kuida brand name and operates Zerenia clinic in Medellin and Peru. The company has 150.72 M outstanding shares. More on Khiron Life Sciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Khiron Life OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Khiron Life's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Khiron Life or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Khiron Life Sciences generated a negative expected return over the last 90 days
Khiron Life Sciences has some characteristics of a very speculative penny stock
Khiron Life Sciences has high historical volatility and very poor performance
The company reported the revenue of 8.95 M. Net Loss for the year was (20.3 M) with profit before overhead, payroll, taxes, and interest of 7.01 M.
Khiron Life Sciences has accumulated about 7.06 M in cash with (22.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Latest headline from Uneven Medical Cannabis Regulatory Landscape Across Europe and EU Reveals Gaps in Access for Patients, Challenges for Cannabis Industry - Yahoo Finance
Legal NameKhiron Life Sciences
CEO, DirectorAnthony Viele  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Khiron Life's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Khiron Life Sciences [KHRNF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with current market capitalization of 33.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Khiron Life's market, we take the total number of its shares issued and multiply it by Khiron Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Khiron Life Sciences classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 150.72 M outstanding shares. Khiron Life Sciences has accumulated about 7.06 M in cash with (22.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Check Khiron Life Probability Of Bankruptcy
Khiron Life Sciences maintains a total of one hundred fifty million seven hundred twenty thousand outstanding shares. Khiron Life Sciences secures 5.26 % if its outstanding shares held by insiders and 5.26 % owned by institutional investors . Please note that no matter how much assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Khiron Ownership Details

Khiron Stock Price Odds Analysis

What are Khiron Life's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Khiron Life jumping above the current price in 90 days from now is about 84.93%. The Khiron Life Sciences probability density function shows the probability of Khiron Life otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon the otc stock has a beta coefficient of 1.0632. This indicates Khiron Life Sciences market returns are highly-sensitive to returns on the market. As the market goes up or down, Khiron Life is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Khiron Life Sciences is significantly underperforming DOW.
 Odds Down 0.22HorizonTargetOdds Up 0.22 
14.91%90 days
Based on a normal probability distribution, the odds of Khiron Life to move above the current price in 90 days from now is about 84.93 (This Khiron Life Sciences probability density function shows the probability of Khiron OTC Stock to fall within a particular range of prices over 90 days) .

Khiron Life Sciences Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Khiron Life market risk premium is the additional return an investor will receive from holding Khiron Life long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Khiron Life. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Khiron Life's alpha and beta are two of the key measurements used to evaluate Khiron Life's performance over the market, the standard measures of volatility play an important role as well.

Khiron Stock Against Markets

Picking the right benchmark for Khiron Life otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Khiron Life otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Khiron Life is critical whether you are bullish or bearish towards Khiron Life Sciences at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Khiron Life without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Rebalancing Now


Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Khiron Life Corporate Executives

Elected by the shareholders, the Khiron Life's board of directors comprises two types of representatives: Khiron Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Khiron. The board's role is to monitor Khiron Life's management team and ensure that shareholders' interests are well served. Khiron Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Khiron Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
Darren Collins - CFO, Corporate SecretaryProfile
Wendy Kaufman - CFOProfile
Please see Stocks Correlation. Note that the Khiron Life Sciences information on this page should be used as a complementary analysis to other Khiron Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Khiron OTC Stock analysis

When running Khiron Life Sciences price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
The market value of Khiron Life Sciences is measured differently than its book value, which is the value of Khiron that is recorded on the company's balance sheet. Investors also form their own opinion of Khiron Life's value that differs from its market value or its book value, called intrinsic value, which is Khiron Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Khiron Life's market value can be influenced by many factors that don't directly affect Khiron Life Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Khiron Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Khiron Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Khiron Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.